and his team joined Omar Khafagy, Manager, Corporate Access, TMX Group, to celebrate the Company’s new listing on the TSX Venture Exchange and to close the market.
They digitize drug research and development, laboratory testing, regulatory approvals, and pharmaceutical manufacturing on a single, unified cloud platform that is cost-effective, ready to deploy, and easy to use.